Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Schulz

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
Annals of Neurology|September 7, 2004
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variantAngela Schulz, Sumeer Dhar, Svetlana Rylova, et al.
Atherosclerosis|November 20, 2015
Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodiesGerd Wallukat, Johannes Müller, Annekathrin Haberland, et al.
Autophagy|June 16, 2015
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathwayGiuseppina Di Fruscio, Angela Schulz, Rossella De Cegli, et al.
Life Sciences|July 29, 2009
Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failureSimone Gschwend, Marcel Bernhard Haug, Marc Nierhaus, et al.
Developmental Medicine and Child Neurology|May 26, 2017
Phenotype and natural history of variant late infantile ceroid-lipofuscinosis 5Alessandro Simonati, Ruth E Williams, Nardo Nardocci, et al.
Kidney International|June 26, 2002
Impaired coronary endothelial function in a rat model of spontaneous albuminuriaSimone Gschwend, Sara-Joan Pinto-Sietsma, Hendrik Buikema, et al.
Life Sciences|October 23, 2022
15-keto-Prostaglandin E<sub>2</sub> exhibits bioactive role by modulating glomerular cytoarchitecture through EP2/EP4 receptorsAikaterini Kourpa, Debora Kaiser-Graf, Anje Sporbert, et al.
Frontiers in Cell and Developmental Biology|May 30, 2023
Reduced urine volume and changed renal sphingolipid metabolism in P2ry14-deficient miceFabian Baalmann, Jana Brendler, Anne Butthof, et al.
Frontiers in Neurology|March 31, 2025
Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfaAngela Schulz, Christoph Schwering, Eva Wibbeler, et al.
Neuropediatrics|July 17, 2022
Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case ReportChristoph Schwering, Sofia Apostolidou, Philipp Deindl, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
Annals of Neurology|September 7, 2004
Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variantAngela Schulz, Sumeer Dhar, Svetlana Rylova, et al.
Atherosclerosis|November 20, 2015
Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodiesGerd Wallukat, Johannes Müller, Annekathrin Haberland, et al.
Autophagy|June 16, 2015
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathwayGiuseppina Di Fruscio, Angela Schulz, Rossella De Cegli, et al.
Life Sciences|July 29, 2009
Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failureSimone Gschwend, Marcel Bernhard Haug, Marc Nierhaus, et al.
Developmental Medicine and Child Neurology|May 26, 2017
Phenotype and natural history of variant late infantile ceroid-lipofuscinosis 5Alessandro Simonati, Ruth E Williams, Nardo Nardocci, et al.
Kidney International|June 26, 2002
Impaired coronary endothelial function in a rat model of spontaneous albuminuriaSimone Gschwend, Sara-Joan Pinto-Sietsma, Hendrik Buikema, et al.
Life Sciences|October 23, 2022
15-keto-Prostaglandin E<sub>2</sub> exhibits bioactive role by modulating glomerular cytoarchitecture through EP2/EP4 receptorsAikaterini Kourpa, Debora Kaiser-Graf, Anje Sporbert, et al.
Frontiers in Cell and Developmental Biology|May 30, 2023
Reduced urine volume and changed renal sphingolipid metabolism in P2ry14-deficient miceFabian Baalmann, Jana Brendler, Anne Butthof, et al.
Frontiers in Neurology|March 31, 2025
Real-world clinical outcomes of patients with CLN2 disease treated with cerliponase alfaAngela Schulz, Christoph Schwering, Eva Wibbeler, et al.
Neuropediatrics|July 17, 2022
Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case ReportChristoph Schwering, Sofia Apostolidou, Philipp Deindl, et al.
Pageof 19